India Glycols Limited (NSE:INDIAGLYCO) — Stock Price
India Glycols Limited (NSE:INDIAGLYCO) is currently trading at Rs1084.80 INR, down 5.14% today. Over the past 52 weeks, shares have ranged between Rs806.80 and Rs1184.45. This page tracks India Glycols Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of India Glycols Limited.
India Glycols Limited (INDIAGLYCO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks India Glycols Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
India Glycols Limited Income Statement — Revenue, Profit & Earnings by Year
India Glycols Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs42.11 Billion | Rs37.68 Billion | Rs32.94 Billion | Rs26.37 Billion | Rs28.68 Billion |
| Cost of Revenue | Rs33.50 Billion | Rs27.70 Billion | Rs27.80 Billion | Rs15.82 Billion | Rs19.68 Billion |
| Gross Profit | Rs8.61 Billion | Rs9.99 Billion | Rs10.55 Billion | Rs10.69 Billion | Rs8.45 Billion |
| Research & Development | — | — | Rs83.17 Million | Rs44.12 Million | Rs46.56 Million |
| SG&A | — | Rs511.41 Million | Rs501.35 Million | Rs475.47 Million | Rs291.22 Million |
| Total Operating Expenses | Rs3.67 Billion | Rs7.53 Billion | Rs1.96 Billion | Rs914.33 Million | Rs5.26 Billion |
| Operating Income | Rs4.94 Billion | Rs2.46 Billion | Rs3.19 Billion | Rs9.39 Billion | Rs1.85 Billion |
| EBITDA | Rs6.49 Billion | Rs5.11 Billion | Rs4.28 Billion | Rs3.47 Billion | Rs4.98 Billion |
| EBIT | Rs4.94 Billion | Rs3.96 Billion | Rs3.27 Billion | Rs2.54 Billion | Rs4.18 Billion |
| Interest Expense | Rs1.67 Billion | Rs1.64 Billion | Rs1.21 Billion | Rs999.63 Million | Rs696.59 Million |
| Income Before Tax | Rs3.77 Billion | Rs2.92 Billion | Rs2.23 Billion | Rs1.65 Billion | Rs3.69 Billion |
| Income Tax Expense | Rs844.50 Million | Rs614.00 Million | Rs503.22 Million | Rs239.60 Million | Rs394.26 Million |
| Net Income | Rs2.93 Billion | Rs2.31 Billion | Rs1.73 Billion | Rs1.25 Billion | Rs3.40 Billion |
India Glycols Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes India Glycols Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs65.23 Billion | Rs61.76 Billion | Rs56.17 Billion | Rs48.58 Billion | Rs46.31 Billion |
| Total Current Assets | Rs14.98 Billion | Rs18.16 Billion | Rs19.45 Billion | Rs16.46 Billion | Rs16.07 Billion |
| Cash & Equivalents | — | Rs706.00 Million | — | Rs1.11 Billion | — |
| Short-term Investments | Rs570.60 Million | Rs478.55 Million | Rs476.85 Million | Rs456.99 Million | Rs360.19 Million |
| Net Receivables | Rs3.51 Billion | Rs3.65 Billion | Rs5.00 Billion | Rs6.06 Billion | Rs6.71 Billion |
| Inventory | Rs8.91 Billion | Rs11.71 Billion | Rs11.06 Billion | Rs7.54 Billion | Rs6.93 Billion |
| Property, Plant & Equipment | — | Rs39.24 Billion | Rs32.80 Billion | Rs28.32 Billion | Rs25.52 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs35.90 Billion | Rs39.20 Billion | Rs35.66 Billion | Rs29.57 Billion | Rs28.58 Billion |
| Total Current Liabilities | Rs20.14 Billion | Rs23.21 Billion | Rs23.75 Billion | Rs18.65 Billion | Rs17.49 Billion |
| Long-term Debt | Rs9.19 Billion | Rs10.40 Billion | Rs7.25 Billion | Rs5.51 Billion | Rs5.40 Billion |
| Net Debt | Rs16.41 Billion | Rs18.14 Billion | Rs13.21 Billion | Rs11.10 Billion | Rs10.35 Billion |
| Total Stockholder Equity | Rs29.33 Billion | Rs22.56 Billion | Rs20.51 Billion | Rs19.01 Billion | Rs17.92 Billion |
| Retained Earnings | — | Rs20.71 Billion | Rs18.65 Billion | Rs17.15 Billion | Rs16.06 Billion |
India Glycols Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how India Glycols Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs6.51 Billion | Rs3.62 Billion | Rs4.39 Billion | Rs3.26 Billion | Rs1.16 Billion |
| Capital Expenditures | Rs8.23 Billion | Rs7.60 Billion | Rs5.53 Billion | Rs4.39 Billion | Rs3.80 Billion |
| Free Cash Flow | Rs-1.73 Billion | Rs-3.98 Billion | Rs-1.14 Billion | Rs-1.13 Billion | Rs-2.64 Billion |
| Investing Cash Flow | Rs-8.17 Billion | Rs-7.36 Billion | Rs-5.03 Billion | Rs-3.30 Billion | Rs764.47 Million |
| Financing Cash Flow | Rs1.91 Billion | Rs3.54 Billion | Rs899.12 Million | Rs-5.10 Million | Rs-1.89 Billion |
| Dividends Paid | Rs753.10 Million | Rs245.90 Million | Rs229.72 Million | Rs230.40 Million | Rs183.92 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs1.55 Billion | Rs1.15 Billion | Rs1.01 Billion | Rs939.60 Million | Rs802.88 Million |
| Change in Cash | Rs-276.07 Million | Rs-201.17 Million | Rs249.83 Million | Rs-50.80 Million | Rs36.56 Million |
India Glycols Limited Earnings History — EPS Actual vs. Analyst Estimates
Track India Glycols Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 14, 2026 | — | — | — |
| Feb 02, 2026 | — | — | — |
| Nov 05, 2025 | — | — | — |
| Jul 28, 2025 | — | — | — |
| May 26, 2025 | — | — | — |
| Jan 31, 2025 | — | — | — |
| Nov 01, 2024 | — | — | — |
| Jun 24, 2020 | 3.25 | 5.63 | -42.27% |